Eli Lilly Message Board - Msg: 33217706

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 813.64

-0.8%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

Lance Bredvold

From: Moonray	2/26/2021 11:13:48 AM
	1 Recommendation of 636

U.S. buys 100,000 courses of Eli Lilly’s latest antibody treatment Sara Salinas The United States has agreed to purchase 100,000 treatment courses of Eli Lilly’s recently approved antibody treatment for Covid-19. The agreement comes at an initial purchase price of $210 million and includes an option to buy additional supply as needed, up to 1.2 million total treatment courses. The therapeutic from Eli Lilly combines two monoclonal antibodies, bamlanivimab and etesevimab, administered through an IV infusion to treat high-risk Covid patients who are displaying symptoms but have not yet developed severe disease. It received an emergency use authorization from the Food and Drug Administration earlier this month. o~~~ O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next